Francoise Dixon - Mach7 Technologies Head Relations

All Insiders . Australia . 
Stock . Mach7 Technologies . Stakeholders . Insider . Francoise Dixon
M7T Stock   0.39  0.01  2.63%   

Executive

Francoise Dixon is Head Relations of Mach7 Technologies
Phone802 861 7745
Webhttps://www.mach7t.com

Mach7 Technologies Management Efficiency

The company has return on total asset (ROA) of (0.0688) % which means that it has lost $0.0688 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0977) %, meaning that it generated substantial loss on money invested by shareholders. Mach7 Technologies' management efficiency ratios could be used to measure how well Mach7 Technologies manages its routine affairs as well as how well it operates its assets and liabilities.
Mach7 Technologies has accumulated 1.27 M in total debt. Debt can assist Mach7 Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Mach7 Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mach7 Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mach7 to invest in growth at high rates of return. When we think about Mach7 Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

AGIA BAApiam Animal Health
N/A
James CAAustralian United Investment
N/A
LLM FCISApiam Animal Health
N/A
Richard EibrandOneview Healthcare PLC
N/A
CPA BAccApiam Animal Health
N/A
Brian MBAApiam Animal Health
N/A
Darragh LyonsOneview Healthcare PLC
44
Duncan RuncimanApiam Animal Health
N/A
Niall ONeillOneview Healthcare PLC
N/A
Stuart CPANational Storage REIT
N/A
LLB BANational Storage REIT
N/A
Colin HackwoodOneview Healthcare PLC
N/A
Toni PettitOneview Healthcare PLC
N/A
John KellyOneview Healthcare PLC
N/A
Renee BScApiam Animal Health
N/A
Manny LynchNational Storage REIT
N/A
JP HoweOneview Healthcare PLC
N/A
Declan BrightOneview Healthcare PLC
N/A
Claire LLBNational Storage REIT
N/A
Mach7 Technologies (M7T) is traded on Australian Securities Exchange in Australia and employs 11 people.

Management Performance

Return On Equity-0.0977
Return On Asset-0.0688

Mach7 Technologies Leadership Team

Elected by the shareholders, the Mach7 Technologies' board of directors comprises two types of representatives: Mach7 Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mach7. The board's role is to monitor Mach7 Technologies' management team and ensure that shareholders' interests are well served. Mach7 Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mach7 Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Kelly Kimball, Vice Culture
Bob Tranchida, Vice Marketing
Michael Lampron, MD CEO
Francoise Dixon, Head Relations
Rebecca Thompson, Head Relations
ACIS ACIS, Company Secretary
Steven Parkes, Global Officer
Dyan OHerne, Chief Officer
David Madaffri, Chief Officer
ACIS AGIA, Company Secretary
Veronique MorganSmith, Company Sec

Mach7 Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mach7 Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.0977
Return On Asset-0.0688
Profit Margin(0.16) %
Operating Margin(0.19) %
Current Valuation70.54 M
Shares Outstanding241.24 M
Shares Owned By Insiders27.10 %
Shares Owned By Institutions25.28 %
Price To Book1.78 X
Price To Sales2.77 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Mach7 Stock Analysis

When running Mach7 Technologies' price analysis, check to measure Mach7 Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mach7 Technologies is operating at the current time. Most of Mach7 Technologies' value examination focuses on studying past and present price action to predict the probability of Mach7 Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mach7 Technologies' price. Additionally, you may evaluate how the addition of Mach7 Technologies to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY